AlphaCore Aiming High with Recombinant LCAT
AlphaCore Pharma Inc. has maintained a low profile since its founding in 2007, befitting a biotech working in the rare orphan indication of familial LCAT deficiency. The inherited condition causes corneal opacities, anemia and renal disease due to the accumulation of LCAT substrates (unesterified cholesterol and phospholipid).
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST